SkinBioTherapeutics (SBTX) RNS Announcements

Add to Alert list
Date Time Source Announcement
03 Oct 2017 07:00 AM
RNS
Cytotoxicity results and scientific update
27 Sep 2017 09:00 AM
RNS
Notice of Results
12 Sep 2017 08:54 AM
RNS
Holding(s) in Company
19 Jun 2017 09:00 AM
RNS
SkinBioTherapeutics to Present at Investor Evening
09 Jun 2017 10:38 AM
RNS
Holding(s) in Company
23 May 2017 03:21 PM
RNS
Holding(s) in Company
23 May 2017 07:00 AM
RNS
Extension of Research Contract
05 Apr 2017 07:00 AM
RNS
First day of dealings - to trade under SBTX ticker

SkinBioTherapeutics is a life science company that develops technologies to improve health by harnessing the human microbiome.

SkinBioTherapeutics is based in Newcastle upon Tyne, United Kingdom.

SkinBioTherapeutics is listed in London under the ticker SBTX.

SBTX share price listed at 16p in 2017.

UK 100

Latest directors dealings